Loss of orally administered drugs in GI tract.

Loss of orally administered drugs in GI tract.

Item
http://www.wikidata.org/entity/Q38130231
A Steady-State Head-to-Head Pharmacokinetic Comparison of All FK-506 (Tacrolimus) Formulations (ASTCOFF): An Open-Label, Prospective, Randomized, Two-Arm, Three-Period Crossover Study.Once-daily LCP-Tacro MeltDose tacrolimus for the prophylaxis of organ rejection in kidney and liver transplantations.Oral drug absorption in pediatrics: the intestinal wall, its developmental changes and current tools for predictions.Nanocarriers protecting toward an intestinal pre-uptake metabolism.Investigation of omeprazole and phenacetin first-pass metabolism in humans using a microscale bioreactor and pharmacokinetic models.Microradiopharmaceutical for Metastatic Melanoma.Priming the body to receive the therapeutic agent to redefine treatment benefit/risk profile.Drug Delivery System for Emodin Based on Mesoporous Silica SBA-15.Stability of bovine lactoferrin in luminal extracts and mucosal homogenates from rat intestine: a prelude to oral absorptionEgg perivitelline fluid of the invasive snail affects mice gastrointestinal function and morphology
P2860

Loss of orally administered drugs in GI tract.

Item
http://www.wikidata.org/entity/Q38130231
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Loss of orally administered drugs in GI tract.
@en
type
label
Loss of orally administered drugs in GI tract.
@en
prefLabel
Loss of orally administered drugs in GI tract.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Loss of orally administered drugs in GI tract
@en
P2093
Yogeshkumar Nanasaheb Gavhane
P2860
P304
P31
P356
10.1016/J.JSPS.2012.03.005
P433
P478
P50
P577
P5875
P698
P932